Formic Acid

Formic Acid

SCHEMBL17065262

NC(=O)c1cccs1.O=CO

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 2/20 0.56
CES1 P23141 2/20 0.56
DAO P14920 1/20 0.54
NPC1 O15118 6/20 0.50
RAB9A P51151 6/20 0.50
KMT2A Q03164 6/20 0.50
MEN1 O00255 5/20 0.50
ALDH1A1 P00352 3/20 0.50
LMNA P02545 2/20 0.50
POLB P06746 1/20 0.50
HDAC1 Q13547 1/20 0.50
MAPK10 P53779 1/20 0.47
HPGD P15428 3/20 0.47
KEAP1 Q14145 1/20 0.47
HTT P42858 1/20 0.47
HPGDS O60760 1/20 0.47
GSK3B P49841 1/20 0.47
TDP1 Q9NUW8 1/20 0.46
MAPT P10636 4/20 0.45
SMN1; SMN2 Q16637 3/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL120212 0.91
SCHEMBL937615 0.91
Urea SCHEMBL4239865 0.89 CES2 (0.62) CES2CES1DAONPC1RAB9A
Hydrochloric Acid SCHEMBL3194035 0.89 CES2 (0.62) CES2CES1DAONPC1RAB9A
Hydrochloric Acid SCHEMBL485645 0.89
Cyclopentane SCHEMBL29102054 0.85 CES2 (0.58) CES2CES1DAONPC1RAB9A
Sulfuric Acid SCHEMBL28129454 0.83 CES2 (0.56) CES2CES1DAONPC1RAB9A
Phosphoric Acid SCHEMBL28129466 0.83 CES2 (0.56) CES2CES1DAONPC1RAB9A
SCHEMBL30385820 0.83 DAO (0.58) CES2CES1DAONPC1RAB9A
Isopropylamine SCHEMBL28222054 0.82 RAB9A (0.55) CES2CES1DAONPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3114124-A1 BENZIMIDAZOLE DERIVATIVES AS RLK and ITK INHIBITORS PRINCIPIA BIOPHARMA, INC. (US) 2017-01-11 EP disclosed
WO-2015134210-A1 BENZIMIDAZOLE DERIVATIVES AS RLK and ITK INHIBITORS PRINCIPIA BIOPHARMA, INC. (US) 2015-09-11 WO disclosed